Agilent Technologies, Inc. $A Shares Acquired by NewEdge Advisors LLC

Key Points

• NewEdge Advisors increased its Agilent Technologies stake by 58.5% in the second quarter, purchasing 10,505 additional shares and bringing its holdings to 28,456 shares valued at approximately $3.78 million.
• Agilent reported quarterly EPS of $1.62, exceeding the $1.49 analyst consensus, while revenue reached $1.88 billion, up 8.1% year over year and above expectations.
• The stock opened at $150.39, and analysts maintain a “Moderate Buy” consensus with an average price target of $170.33; several firms recently raised their targets, including JPMorgan to $190.

NewEdge Advisors LLC increased its holdings in Agilent Technologies, Inc. (NYSE:A - Free Report) by 58.5% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 28,456 shares of the medical research company's stock after purchasing an additional 10,505 shares during the period. NewEdge Advisors LLC's holdings in Agilent Technologies were worth $3,780,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the business. IFP Advisors Inc lifted its position in Agilent Technologies by 14.3% during the second quarter. IFP Advisors Inc now owns 2,080 shares of the medical research company's stock worth $276,000 after buying an additional 261 shares during the period. Baird Financial Group Inc. grew its holdings in Agilent Technologies by 53.8% in the 2nd quarter. Baird Financial Group Inc. now owns 91,342 shares of the medical research company's stock valued at $12,133,000 after buying an additional 31,940 shares during the period. Allworth Financial LP grew its holdings in Agilent Technologies by 50.6% in the 2nd quarter. Allworth Financial LP now owns 20,420 shares of the medical research company's stock valued at $2,712,000 after buying an additional 6,860 shares during the period. Arizona State Retirement System increased its stake in shares of Agilent Technologies by 5.2% during the 2nd quarter. Arizona State Retirement System now owns 81,025 shares of the medical research company's stock valued at $10,763,000 after acquiring an additional 3,985 shares during the last quarter. Finally, West Family Investments Inc. acquired a new position in shares of Agilent Technologies during the 2nd quarter valued at about $622,000.

Agilent Technologies Stock Performance

NYSE A opened at $150.39 on Wednesday. The firm has a market capitalization of $42.40 billion, a P/E ratio of 29.60, a P/E/G ratio of 2.23 and a beta of 1.24. Agilent Technologies, Inc. has a 1-year low of $108.35 and a 1-year high of $163.75. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.05 and a quick ratio of 1.56. The business's 50-day simple moving average is $144.41 and its 200-day simple moving average is $128.99.

Agilent Technologies (NYSE:A - Get Free Report) last issued its earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.49 by $0.13. The business had revenue of $1.88 billion during the quarter, compared to analysts' expectations of $1.84 billion. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%.The company's revenue for the quarter was up 8.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.37 EPS. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Equities analysts predict that Agilent Technologies, Inc. will post 6.2 EPS for the current year.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, Director Mikael Dolsten sold 634 shares of the business's stock in a transaction that occurred on Friday, September 4th. The shares were sold at an average price of $151.38, for a total transaction of $95,974.92. Following the completion of the sale, the director directly owned 4,924 shares in the company, valued at $745,395.12. The trade was a 11.41% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on the stock. Wells Fargo & Company decreased their target price on shares of Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating on the stock in a research report on Thursday, May 28th. Royal Bank Of Canada upped their price target on shares of Agilent Technologies from $155.00 to $185.00 and gave the stock an "outperform" rating in a research report on Thursday, August 27th. JPMorgan Chase & Co. increased their price target on shares of Agilent Technologies from $180.00 to $190.00 and gave the stock an "overweight" rating in a research note on Thursday, August 27th. HSBC decreased their price target on shares of Agilent Technologies from $180.00 to $165.00 and set a "buy" rating on the stock in a report on Wednesday, June 3rd. Finally, Sanford C. Bernstein boosted their price objective on shares of Agilent Technologies from $155.00 to $180.00 and gave the company an "outperform" rating in a research note on Thursday, August 27th. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, Agilent Technologies presently has a consensus rating of "Moderate Buy" and a consensus price target of $170.33.

Agilent Technologies Profile

Agilent Technologies, Inc is a global provider of analytical instruments, laboratory software, consumables and services used by organizations in the life sciences, diagnostics, pharmaceutical, chemical, environmental and food industries. Its solutions help customers analyze the composition and quality of substances, develop and manufacture products, and conduct research and testing.

The company's offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic analysis equipment, automated electrophoresis systems, laboratory informatics software, columns and other consumables.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.